August 22, 2025BiologyOpen Access

Exploring Metabolic and Immunological Biomarkers for Oral Squamous Cell Carcinoma: Potential Targets for Precision Therapy

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review highlights biomarkers for oral squamous cell carcinoma, suggesting new targets for precision therapy and improved diagnostics.

Identifying metabolic and immunological biomarkers can enhance early detection of oral squamous cell carcinoma, reducing mortality rates.
Current diagnostic strategies for oral squamous cell carcinoma face limitations, leading to high recurrence and misdiagnosis in many cases.
Analysis summarizes existing metabolic pathways and immune microenvironment alterations as potential therapeutic targets in clinical trials.
Understanding these biomarkers could revolutionize treatment options for oral squamous cell carcinoma, improving patient outcomes.

Rajneesh et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review highlights biomarkers for oral squamous cell carcinoma, suggesting new targets for precision therapy and improved diagnostics.